Rhabdomyosarcoma in adults: new perspectives on therapy

Area of Science:

• Pediatric Oncology
• Medical Genetics
• Cancer Biology

Background:

• Rhabdomyosarcoma (RMS) is primarily recognized as a pediatric malignancy, with extensive research focusing on its biology, genetics, and treatment in children.
• Significant survival improvements in pediatric RMS over the past two decades are attributed to well-described subtypes like embryonic and alveolar RMS.
• Adult RMS, particularly the pleomorphic subtype, is rare, presenting challenges in research and understanding its unique biological and genetic characteristics.

Purpose of the Study:

• To highlight the knowledge gaps in adult Rhabdomyosarcoma (RMS), including its biology, genetics, and risk factors, compared to the pediatric population.
• To emphasize the lack of standardized treatment protocols for adult RMS and its impact on patient prognosis and overall survival.
• To explore emerging therapeutic strategies, such as immunotherapy, for adult RMS and advocate for tailored treatment approaches.

Main Methods:

• Review of existing literature on Rhabdomyosarcoma (RMS) in both pediatric and adult populations.
• Comparative analysis of the understanding of RMS biology, genetics, and treatment between age groups.
• Exploration of current and potential future treatment modalities, including immunotherapy.

Main Results:

• Adult Rhabdomyosarcoma (RMS), especially the pleomorphic subtype, is poorly understood regarding its underlying biology and genetics.
• Adult RMS patients face a poor prognosis due to low incidence, leading to challenges in research and the absence of standardized treatment plans.
• Current treatments for adult RMS are not standardized, negatively impacting survival rates compared to other adult sarcomas.

Conclusions:

• There is a critical need for standardized treatment protocols and further research into the specific biology and genetics of Rhabdomyosarcoma (RMS) in adults.
• Emerging therapies, including immunotherapy, show promise but require dedicated investigation for effective application in adult RMS patients.
• Addressing the unique challenges in adult RMS is essential to improve patient outcomes and survival rates, drawing parallels from pediatric successes.